Overview
- Editors:
-
-
Murray B. Stein
-
Dept. Psychiatry, University of California, San Diego, La Jolla, USA
-
Thomas Steckler
-
Research & Development, CNS - Affective Spectrum, Johnson & Johnson Pharmaceutical, Beerse, Belgium
Access this book
Other ways to access
Table of contents (23 chapters)
-
-
- O. Joseph Bienvenu, Lisa A. Wuyek, Murray B. Stein
Pages 3-19
-
- Ronald C. Kessler, Ayelet Meron Ruscio, Katherine Shear, Hans-Ulrich Wittchen
Pages 21-35
-
- Kathleen Ries Merikangas, Sonja Alsemgeest Swanson
Pages 37-59
-
- Katharina Domschke, Jürgen Deckert
Pages 63-75
-
- Newton Sabino Canteras, Leonardo Barbosa Resstel, Leandro José Bertoglio, Antonio de Pádua Carobrez, Francisco Silveira Guimarães
Pages 77-96
-
- Pêgo J. M, Sousa J. C, Almeida OFX, Sousa N
Pages 97-118
-
- Dallas Treit, Elif Engin, Kris McEown
Pages 121-160
-
- Laura H. Jacobson, John F. Cryan
Pages 161-201
-
-
- M. A. Van Duinen, V. Niccolai, E. J. L. Griez
Pages 229-250
-
-
- Dennis C. Choi, Barbara O. Rothbaum, Maryrose Gerardi, Kerry J. Ressler
Pages 279-299
-
- C. Durant, D. Christmas, D. Nutt
Pages 303-330
-
-
- Anton Y. Bespalov, Marcel M. van Gaalen, Gerhard Gross
Pages 361-390
-
- Will Spooren, Anne Lesage, Hilde Lavreysen, Fabrizio Gasparini, Thomas Steckler
Pages 391-413
-
-
- FabrÃcio A. Moreira, Carsten T. Wotjak
Pages 429-450
-
- David S. Baldwin, Khalil I. Ajel, Matthew Garner
Pages 453-467
About this book
The book is part of a series on Current Topics in Behavioral Neurosciences, which has as its focus anxiety and its treatment. We have brought together a distinguished cadre of authors with the aim of covering a broad array of topics related to anxiety disorders, ranging from clinical diagnosis, epidemiology, preclinical neuroscience, and animal models to established and innovative therapeutic approaches. The book aims at bridging these disciplines to provide an update of literature relevant to understanding anxiety, its consequences, and its management. Following is a brief overview of the chapters and their content, meant to serve as a guide to navigating the book. The ?rst section covers clinical aspects of anxiety disorders. Joe Bienvenu and colleagues provide an incisive overview of diagnostic considerations in the anxiety disorders in which they emphasize the strengths and shortcomings of our current nosologic systems. This is followed by a review and update of the epidemiology of anxiety disorders by Ron Kessler and colleagues, which provides an authoritative survey of anxiety disorder incidence, prevalence, and risk factors. This is comp- mented by a comprehensive review of the literature on disorders that co-occur with anxiety disorders by Kathleen Merikangas and Sonja Alsemgeest Swanson. Their review highlights the tremendous comorbidity that occurs not only within the anxiety disorders, but also with other mental and physical health conditions.
Editors and Affiliations
-
Dept. Psychiatry, University of California, San Diego, La Jolla, USA
Murray B. Stein
-
Research & Development, CNS - Affective Spectrum, Johnson & Johnson Pharmaceutical, Beerse, Belgium
Thomas Steckler